0.635
0.64 (0%)
As of Dec 20, 2024
Karyopharm Therapeutics Inc. [KPTI]
Source:
Company Overview
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development and commercialization of first-in-class drugs directed against nuclear export for the treatment of cancer and other diseases.
| Country | United States |
| Headquarters | newton, massachusetts |
| Phone Number | (617) 658-0600 |
| Industry | manufacturing |
| CEO | Richard Paulson |
| Website | www.karyopharm.com |